Evidence map›Paper›PMID 19545642›Full record

ReviewProstaglandins & other lipid mediators2010

Epoxyeicosanoid signaling in CNS function and disease.

Jeffrey J Iliff, Jia Jia, Jonathan Nelson, Toru Goyagi, Judy Klaus, Nabil J Alkayed

Abstract readReview
In one paragraph

Review in Prostaglandins & other lipid mediators, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 134 citations in OpenAlex.

  1. Trial
  2. The Roles of EETs in Neurological Disorders.CNS neuroscience & therapeutics · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Jeffrey J IliffDepartment of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR, USA.
Jia Jia
Jonathan Nelson
Toru Goyagi
Judy Klaus
Nabil J Alkayed
Oregon Health & Science University · USAkita University · JPJohns Hopkins University · USNanjing University · CN

Funding

TIA-Induced Ischemic Tolerance via P450 EpoxygenaseR01NS044313 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2002 to 2015
$4.9M
Mechanism of Vascular Dysfunction after Stroke in Postmenopausal FemaleR01NS070837 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2011 to 2015
$1.7M
P450 Eicosannoids: Novel Nerve-Deerived Relaxing Factors in the BrainF31NS060498 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ILIFF, JEFFREY J · 2007 to 2009
$114k
NINDS NIH HHS F31 NS060498NINDS NIH HHS R01 NS044313NINDS NIH HHS R01 NS070837
6 · The paper itself

Abstract

Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites of cytochrome P450 epoxygenase enzymes recognized as key players in vascular function and disease, primarily attributed to their potent vasodilator, anti-inflammatory and pro-angiogenic effects. Although EETs' actions in the central nervous system (CNS) appear to parallel those in peripheral tissue, accumulating evidence suggests that epoxyeicosanoid signaling plays different roles in neural tissue compared to peripheral tissue; roles that reflect distinct CNS functions, cellular makeup and intercellular relationships. This is exhibited at many levels including the expression of EETs-synthetic and -metabolic enzymes in central neurons and glial cells, EETs' role in neuro-glio-vascular coupling during cortical functional activation, the capacity for interaction between epoxyeicosanoid and neuroactive endocannabinoid signaling pathways, and the regulation of neurohormone and neuropeptide release by endogenous EETs. The ability of several CNS cell types to produce and respond to EETs suggests that epoxyeicosanoid signaling is a key integrator of cell-cell communication in the CNS, coordinating cellular responses across different cell types. Under pathophysiological conditions, such as cerebral ischemia, EETs protect neurons, astroglia and vascular endothelium, thus preserving the integrity of cellular networks unique to and essential for proper CNS function. Recognition of EETs' intimate involvement in CNS function in addition to their multi-cellular protective profile has inspired the development of therapeutic strategies against CNS diseases such as cerebral ischemia, tumors, and neural pain and inflammation that are based on targeting the cellular actions of EETs or their biosynthetic and metabolizing enzymes. Based upon the emerging importance of epoxyeicosanoids in cellular function and disease unique to neural systems, we propose that the actions of "neuroactive EETs" are best considered separately, and not in aggregate with all other peripheral EETs functions.

Indexed as

Signal TransductionAnimalsBrainCentral Nervous SystemCentral Nervous System DiseasesEicosanoidsHumansEicosanoids

Identifiers

PMID19545642
PMCPMC2844927
OpenAlexW2023363608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.